Childhood obesity

Child and Adolescent Psychiatric Clinics of North America

Volumn 11, Issue 2, 2002, Pages 257-278

  Morgan, Christina M ^a,b   Tanofsky Kraff, Marian ^b,c   Wilfley, Denise E ^d   Yanovski, Jack A ^b,e  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CATHOLIC UNIVERSITY OF AMERICA   (United States)

^d SAN DIEGO STATE UNIVERSITY   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT DISEASE; BEHAVIOR THERAPY; CHILD; CHILDHOOD DISEASE; DIET THERAPY; GENETIC PREDISPOSITION; HUMAN; LIPID STORAGE; METABOLIC DISORDER; OBESITY; PARENT; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; REVIEW; SOCIAL ASPECT; STOMACH BYPASS; BODY HEIGHT; BODY MASS; BODY WEIGHT; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; MALE; MULTIMODALITY CANCER THERAPY; RISK FACTOR;

BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMAN; MALE; OBESITY; RISK FACTORS; HUMANS;

EID: 0035998971     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-4993(01)00007-4     Document Type: Review

References (131)

1. Bodyweight gain induced by psychotropic drugs: Incidence, mechanisms and management
2. Relationship of physical activity and television watching with body weight and level of fatness among children: Results from the Third National Health and Nutrition Examination Survey
3. Gastric bypass for morbid obesity in children and adolescents
4. Weight gain associated with the use of gabapentin
5. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity
6. Body weight gain induced by antipsychotic drugs: Mechanisms and management
7. Obesity evaluation and treatment: Expert committee recommendations
8. Children's attitudes and behavioral intentions toward a peer presented as obese: Does a medical explanation for the obesity make a difference?
9. Weight gain: A side-effect of tricyclic antidepressants
10. The variability of young children's energy intake
11. The effect of physical activity on the body measurements and work capacity of overweight boys
12. Overweight children
13. Genetic influences on body weight and shape
14. Genetics of obesity: Overview and research directions
15. Psychosocial consequences of obesity
16. The heterogeneity of obesity: Fitting treatments to individuals
17. Emotional aspects of obesity in children
18. Risperidone versus pimozide in Tourette's disorder: A comparative double-blind parallel-group study
19. Metabolic impact of obesity in childhood
20. Prevalence and trends in overweight and obesity in three cross sectional studies of British children, 1974-1994
21. Fat intake and nutritional status of children in China
22. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis
23. Changes in ponderosity and blood pressure in childhood. The Muscatine Study
24. Body composition at menarche: The Frisch-Revelle hypothesis revisited
25. Prevalence and trends of overweight among preschool children in developing countries
26. Body mass index as a measure of body fatness: Age-and sex-specific prediction formulas
27. Obesity: What mental health professionals need to know
28. Childhood obesity: Prevalence and effects
29. Blount disease (tibia vara): Another skeletal disorder associated with childhood obesity
30. Critical periods in childhood for the development of obesity
31. Introduction: The use of body mass index to assess obesity in children
32. Factors within the physical environment associated with childhood obesity
33. Use of the body mass index (BMI) as a measure of overweight in children and adolescents
34. Weight gain during treatment with valproate
35. Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life
36. Family-based behavioral intervention for obese children
37. Five-year follow-up of family-based behavioral treatments for childhood obesity
38. Treatment of pediatric obesity
39. Decreasing sedentary behaviors in treating pediatric obesity
40. Do children lose and maintain weight easier than adults: A comparison of child and parent weight changes from six months to ten years
41. Family-based behavioral weight control in obese young children
42. Effects of decreasing sedentary behavior and increasing activity on weight change in obese children
43. Ten-year follow-up of behavioral, family-based treatment for obese children
44. Ten-year outcomes of behavioral family-based treatment for childhood obesity
45. A comparison of lifestyle change and programmed aerobic exercise on weight and fitness changes in obese children
46. Long-term effects of family-based treatment of childhood obesity
47. Comparison of family-based behavior modification and nutrition education for childhood obesity
48. Behavioral treatment of childhood and adolescent obesity: Current status, challenges, and future directions
49. Effects of recombinant leptin therapy in a child with congenital leptin deficiency
50. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency
51. Drugs that cause weight gain
52. Prevalence of obesity with increased blood pressure in elementary school-aged children
53. Comparison of two hypocaloric diets in obese children
54. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
55. Secular increases in relative weight and adiposity among children over two decades. The Bogalusa Heart Study
56. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes
57. Weight gain associated with antipsychotic drugs
58. Confronting the failure of behavioral and dietary treatments for obesity
59. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder
60. Parents as the exclusive agents of change in the treatment of childhood obesity
61. Body stereotyping and stigmatization of obese persons by first graders
62. Metabolic precursors and effects of obesity in children: A decade of progress, 1990-1999
63. Menstrual disorders in adolescents: Excess androgens and the polycystic ovary syndrome
64. Social and economic consequences of overweight in adolescence and young adulthood
65. Is adolescent gastric-restrictive antiobesity surgery warranted?
66. Physical training, lifestyle education, and coronary risk factors in obese girls
67. Altered insulin resistance is associated with increased dietary weight loss in obese children
68. The impact of body mass index of 78,612 18-year-old Dutch men on 32-year mortality from all causes
69. Cholesterol cholelithiasis in adolescent females: Its connection with obesity, parity, and oral contraceptive use. A retrospective study of 31 cases
70. An evaluation of enhanced self-regulation training in the treatment of childhood obesity
71. An evaluation of two methods of parental involvement in treating obese children
72. Empirically supported treatments in pediatric psychology: Pediatric obesity
73. Parents and children's adiposity and eating style
74. Dietary and exercise interventions for juvenile obesity: Long-term effect of behavioral and public health models
75. Application of weight-height ratios and body indices to juvenile populations. The National Health Examination Survey Data
76. Self induced vomiting and laxative and diuretic use among teenagers
77. Body image stereotypes: A developmental comparison
78. Case study: Risperidone-induced hepatotoxicity in pediatric patients
79. School-based intervention for adolescent obesity: Analysis of treatment, randomly selected control, and self-selected control subjects
80. Parental neglect during childhood and increased risk of obesity in young adulthood
81. The epidemiology of bilateral slipped capital femoral epiphysis: A study of children in Michigan
82. Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report
83. Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist
84. Evaluation of pulmonary function and polysomnography in obese children and adolescents
85. A pilot study of the efficacy of orlistat in overweight adolescents
86. Adolescents' weight, sex and family functioning
87. Safety and efficacy of treatment with an ephedrine/caffeine mixture: The first double-blind placebo-controlled pilot study in adolescents
88. Congenital leptin deficiency is associated with severe early-onset obesity in humans
89. Loss of control over eating, adiposity, and psychopathology in overweight children
90. 40-Year follow-up of overweight children
91. Physical activity and diet in 7 to 11 years old children
92. Morbidity and mortality associated with elevated body weight in children and adolescents
93. The disease burden associated with overweight and obesity
94. Long-term effects of dietary counselling on nutrient intake and weight loss in obese children
95. Association between postnatal catch-up growth and obesity in childhood: Prospective cohort study
96. Friendless, fat and dieting: Peer popularity and weight control in 9-year-old girls
97. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents
98. Obesity in young men after famine exposure in utero and early infancy
99. Reduced rate of energy expenditure as a risk factor for body-weight gain
100. Social developmental factors and women's body image attitudes
101. Weight-loss studies test medications as treatments for childhood obesity
102. Behavioural treatment of childhood and adolescent obesity
103. Is parental control over children's eating associated with childhood obesity? Results from a population-based sample of third graders
104. The physiology of body weight regulation: Relevance to the etiology of obesity in children
105. Weight gain associated with use of psychotropic medications
106. Maternal child feeding practices and obesity: A discordant sibling analysis
107. Idiopathic intracranial hypertension in children and adolescents
108. A three-component model of children's teasing: Aggression, humor and ambiguity
109. Socioeconomic status and obesity: A review of the literature
110. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors. The Bogalusa Heart Study
111. How to appease the appetite of psychotropic drugs
112. Gastric bypass surgery in adolescents with morbid obesity
113. The body-mass index of twins who have been reared apart
114. Rethinking side effects of selective serotonin reuptake inhibitors: Sexual dysfunction and weight gain
115. Pediatric obesity treatment and prevention
116. Eating-disordered pathology, body fat, and depression in children and adolescents
117. Development of body image, eating disturbance, and general psychological functioning in female adolescents: Covariance structure modeling and longitudinal investigations
118. Prevalence of fatty liver in Japanese children and relationship to obesity: An epidemiological ultrasonographic survey
119. Overweight children and adolescents: Description, epidemiology, and demographics
120. Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991
121. Childhood obesity: Medical and familial correlates and age of onset
122. Melanocortin-4 receptor mutations are a frequent and heterogenous cause of morbid obesity
123. Nutrient intake of obese children in a family-based behavioral weight control program
124. Body composition in 5-18-year-old obese children and adolescents before and after weight reduction as assessed by deuterium dilution and bioelectrical impedance analysis
125. Predicting obesity in young adulthood from childhood and parental obesity
126. Intensive therapies for pediatric obesity
127. Recent advances in basic obesity research
128. Pediatric obesity
129. Long-term risperidone for pervasive developmental disorder: Efficacy, tolerability, and discontinuation